Sec Form 4 Filing - Deitsch Stephen @ BioScrip, Inc. - 2019-04-18

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Deitsch Stephen 2. Issuer Name and Ticker or Trading Symbol BioScrip, Inc. [ BIOS] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Financial Officer (Last) (First) (Middle) C/O BIOSCRIP, INC., 1600 BROADWAY, SUITE 700 3. Date of Earliest Transaction (MM/DD/YY) 04/18/2019 (Street) DENVER, CO80202 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock, $.0001 Par Value 04/18/2019( 1 ) M 66,902 A $ 0 ( 2 ) 100,300 D Common Stock, $.0001 Par Value 04/18/2019( 3 ) M 19,685 A $ 0 ( 2 ) 119,985 D Common Stock, $.0001 Par Value 04/18/2019 D 25,094 D $ 1.82 ( 4 ) 94,891 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Restricted Stock Unit ( 5 ) 04/18/2019( 1 ) M 66,902 ( 5 ) 12/31/2019 Common Stock, $.0001 Par Value 66,902 ( 2 ) 0 ( 6 ) D Restricted Stock Unit ( 2 ) 04/18/2019( 3 ) M 19,685 ( 7 ) ( 7 ) Common Stock, $.0001 Par Value 19,685 ( 2 ) 39,370 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Deitsch Stephen C/O BIOSCRIP, INC. 1600 BROADWAY, SUITE 700 DENVER, CO80202 Chief Financial Officer Signatures /s/ Stephen Deitsch 04/22/2019 Signature of Reporting Person Date

Explanation of Responses:

( 1 )66,902 Restricted Stock Units (RSUs) vested in January 2019 based on the satisfaction of certain Company stock price trading targets; however, as provided in the grant agreement, the Company deferred settlement of the 66,902 RSUs until April 18, 2019. ( 2 )Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. ( 3 )19,685 RSUs vested on the first anniversary of the original grant date (April 11, 2018); however, as provided in the grant agreement, the Company deferred settlement of the RSUs until April 18, 2019. ( 4 )This transaction represents shares withheld by the Company for tax withholding on Mr. Deitsch's settlement of the two RSU awards described in this Form 4 that were settled on April 18, 2019. ( 5 )Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels. ( 6 )Depending on Company stock price at the end of the performance period, payout may be 0%, 50%, 100% or 150% of reported amount. ( 7 )The remaining 39,370 RSUs vest in two equal installments commencing on the second and third anniversaries of the date of grant (4/11/2018).

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.